Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H20O13 |
Molecular Weight | 480.3757 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@@H](OC2=C3OC(=C(O)C(=O)C3=C(O)C=C2O)C4=CC(O)=C(O)C=C4)[C@H](O)[C@@H](O)[C@@H]1O
InChI
InChIKey=SJRXVLUZMMDCNG-KKPQBLLMSA-N
InChI=1S/C21H20O13/c22-5-11-13(27)15(29)17(31)21(32-11)34-19-10(26)4-9(25)12-14(28)16(30)18(33-20(12)19)6-1-2-7(23)8(24)3-6/h1-4,11,13,15,17,21-27,29-31H,5H2/t11-,13-,15+,17-,21+/m1/s1
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. | 1994 Aug 3 |
|
Application of the electrotopological state index to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors. | 1996 Dec |
|
Inhibition of HIV activation in latently infected cells by flavonoid compounds. | 1996 Jan 1 |
|
Inhibitory activity of flavonoids and tannins against HIV-1 protease. | 2000 Sep |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5281621
Created by
admin on Fri Dec 15 19:50:20 GMT 2023 , Edited by admin on Fri Dec 15 19:50:20 GMT 2023
|
PRIMARY | |||
|
DTXSID60215512
Created by
admin on Fri Dec 15 19:50:20 GMT 2023 , Edited by admin on Fri Dec 15 19:50:20 GMT 2023
|
PRIMARY | |||
|
656276
Created by
admin on Fri Dec 15 19:50:20 GMT 2023 , Edited by admin on Fri Dec 15 19:50:20 GMT 2023
|
PRIMARY | |||
|
652-78-8
Created by
admin on Fri Dec 15 19:50:20 GMT 2023 , Edited by admin on Fri Dec 15 19:50:20 GMT 2023
|
PRIMARY | |||
|
A3Q367XWX9
Created by
admin on Fri Dec 15 19:50:20 GMT 2023 , Edited by admin on Fri Dec 15 19:50:20 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD